^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

rapcabtagene autoleucel (YTB323)

i
Other names: YTB323, YTB-323, YTB 323
Associations
Company:
Novartis
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations